Proteome Sciences (LON:PRM) Stock Falls 1.9% – Here’s What Happened

Proteome Sciences plc (LON:PRM) shares fell 1.9% during trading on Wednesday. The company traded as low as GBX 1.20 and last traded at GBX 1.43. Approximately 139,611 shares were traded during trading, a decline of 60% from the average daily volume of 347,772 shares. The stock had previously closed at GBX 1.46.

Proteome Sciences Price Performance

The company has a debt-to-equity ratio of -161.07, a quick ratio of 0.37 and a current ratio of 0.12. The company has a 50-day moving average price of GBX 1.45 and a 200-day moving average price of GBX 1.63. The firm has a market capitalization of £5.00 million, a P/E ratio of -1.98 and a beta of 0.16.

Proteome Sciences (LON:PRM) last released its quarterly earnings data on Wednesday, September 16th. The company reported GBX (0.41) EPS for the quarter. Proteome Sciences had a negative net margin of 61.46% and a positive return on equity of 23.85%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.